Lucioni M

ORCID: 0000-0002-6244-3646 · 1 paper in corpus
2022
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics12123054

Risk-reducing surgery (RRS) is recommended in BRCA-mutated carriers because of their increased risk of developing ovarian cancer, while its role is still discussed for women harboring mutations in non-BRCA homologous repair genes. The aim o…